Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Fulfaro

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Current Cancer Drug Targets|January 22, 2010
Bortezomib: a new pro-apoptotic agent in cancer treatmentAntonio Russo, Giuseppe Bronte, Fabio Fulfaro, et al.
Current Medical Research and Opinion|December 4, 2012
Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patientsSebastiano Mercadante, Claudio Adile, Riccardo Torta, et al.
Oncology|February 5, 2010
The long and winding road to useful predictive factors for anti-EGFR therapy in metastatic colorectal carcinoma: the KRAS/BRAF pathwayAntonio Russo, Sergio Rizzo, Giuseppe Bronte, et al.
Cancer|February 24, 2009
Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysisAntonio Russo, Sergio Rizzo, Fabio Fulfaro, et al.
Cancer Investigation|September 17, 2016
Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary ReportGaetano Leto, Lorena Incorvaia, Carla Flandina, et al.
Recenti Progressi in Medicina|June 22, 2007
[Oral complications in patients with head and neck cancer after radio-chemotherapy. Mucositis and xerostomia]Chiara Di Liberto, Marino Caroprese, Giuseppe Pizzo, et al.
Clinical & Experimental Metastasis|July 13, 2010
Serum follistatin in patients with prostate cancer metastatic to the boneFrancesca Maria Tumminello, Giuseppe Badalamenti, Fabio Fulfaro, et al.
Anticancer Research|February 16, 2006
Effects of zoledronic acid on proteinase plasma levels in patients with bone metastasesGaetano Leto, Giuseppe Badalamenti, Carlo Arcara, et al.
Journal of Pain and Symptom Management|July 17, 2007
Switching from transdermal drugs: an observational "N of 1" study of fentanyl and buprenorphineSebastiano Mercadante, Giampiero Porzio, Fabio Fulfaro, et al.
Journal of Pain and Symptom Management|March 28, 2006
Low morphine doses in opioid-naive cancer patients with painSebastiano Mercadante, Gianpiero Porzio, Patrizia Ferrera, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Current Cancer Drug Targets|January 22, 2010
Bortezomib: a new pro-apoptotic agent in cancer treatmentAntonio Russo, Giuseppe Bronte, Fabio Fulfaro, et al.
Current Medical Research and Opinion|December 4, 2012
Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patientsSebastiano Mercadante, Claudio Adile, Riccardo Torta, et al.
Oncology|February 5, 2010
The long and winding road to useful predictive factors for anti-EGFR therapy in metastatic colorectal carcinoma: the KRAS/BRAF pathwayAntonio Russo, Sergio Rizzo, Giuseppe Bronte, et al.
Cancer|February 24, 2009
Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysisAntonio Russo, Sergio Rizzo, Fabio Fulfaro, et al.
Cancer Investigation|September 17, 2016
Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary ReportGaetano Leto, Lorena Incorvaia, Carla Flandina, et al.
Recenti Progressi in Medicina|June 22, 2007
[Oral complications in patients with head and neck cancer after radio-chemotherapy. Mucositis and xerostomia]Chiara Di Liberto, Marino Caroprese, Giuseppe Pizzo, et al.
Clinical & Experimental Metastasis|July 13, 2010
Serum follistatin in patients with prostate cancer metastatic to the boneFrancesca Maria Tumminello, Giuseppe Badalamenti, Fabio Fulfaro, et al.
Anticancer Research|February 16, 2006
Effects of zoledronic acid on proteinase plasma levels in patients with bone metastasesGaetano Leto, Giuseppe Badalamenti, Carlo Arcara, et al.
Journal of Pain and Symptom Management|July 17, 2007
Switching from transdermal drugs: an observational "N of 1" study of fentanyl and buprenorphineSebastiano Mercadante, Giampiero Porzio, Fabio Fulfaro, et al.
Journal of Pain and Symptom Management|March 28, 2006
Low morphine doses in opioid-naive cancer patients with painSebastiano Mercadante, Gianpiero Porzio, Patrizia Ferrera, et al.
Pageof 4